Screening the receptorome

Journal of Psychopharmacology

Volumn 20, Issue 4 SUPPL., 2006, Pages 41-46

  Kroeze, Wesley K ^a   Roth, Bryan L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Database; Fen phen; G protein coupled receptors (GPCR); HERG; High throughput screening; Receptorome; Salvinorin A; Selectivity; Weight gain

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALPHA 1 ADRENERGIC RECEPTOR; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CABERGOLINE; CARRIER PROTEIN; DIHYDROERGOTAMINE; ERGOTAMINE; FENFLURAMINE; G PROTEIN COUPLED RECEPTOR; IMIPRAMINE; ION CHANNEL; METHYSERGIDE; MIANSERIN; MIRTAZAPINE; NEUROLEPTIC AGENT; PERGOLIDE; PHENTERMINE; POTASSIUM CHANNEL HERG; RECEPTOR; RECEPTOROME; SALVINORIN A; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

CLINICAL TRIAL; DATA BASE; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DRUG SELECTIVITY; DRUG TARGETING; GENOME; HIGH THROUGHPUT SCREENING; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFORMATION SYSTEM; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; REVIEW; SERIAL ANALYSIS OF GENE EXPRESSION; SIDE EFFECT; VALVULAR HEART DISEASE; WEIGHT GAIN;

ANIMALS; COMPUTATIONAL BIOLOGY; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HUMANS; RECEPTORS, CELL SURFACE; SMALL MOLECULE LIBRARIES; TERMINOLOGY AS TOPIC;

EID: 33750040872     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/1359786806066045     Document Type: Review

References (59)

1. Allison D B, Mentore J L, Heo M, Chandler L P, Cappelleri J C, Infante M C, and Weiden P J (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156: 1686-1696
2. Armbruster B N, Roth B L (2005) Mining the receptorome. J Biol Chem 280: 5129-5132
3. Aronov A M, Goldman B B (2004) A model for identifying HERG K+ channel blockers. Bioorg Med Chem 12: 2307-2315
4. Bains W, Basman A, White C (2004) HERG binding specificity and binding site structure: evidence from a fragment-based evolutionary computing SAR study. Prog Biophys Mol Biol 86: 205-233
5. Bajorath J (2001) Rational drug discovery revisited: interfacing experimental programs with bio- and chemo-informatics. Drug Discov Today 6: 989-995
6. Baxter D F, Kirk M, Garcia A F, Raimondi A, Holmqvist M H, Flint K K, Bojanic D, Distefano P S, Curtis R, Xie Y (2002) A novel membrane potential-sensitive fluorescent dye improves cell-based assays for ion channels. J Biomol Screen 7: 79-85
7. Bock J R, Gough D A (2005) Virtual screen for ligands of orphan G protein-coupled receptors. J Chem Inf Model 45: 1402-1414
8. Bohacek R S, McMartin C, Guida W C (1996) The art and practice of structure-based drug design: a molecular modeling perspective. Med Res Rev 16: 3-50
9. Cavalli A, Poluzzi E, De Ponti F, Recanatini M (2002) Toward a pharmacophore for drugs inducing the long QT syndrome: insights from a CoMFA study of HERG K(+) channel blockers. J Med Chem 45: 3844-3853
10. Chavkin C, Sud S, Jin W, Stewart J, Zjawiony J K, Siebert D J, Toth B A, Hufeisen S J, Roth B L (2004) Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations. J Pharmacol Exp Ther 308: 1197-1203
11. Cianchetta G, Li Y, Kang J, Rampe D, Fravolini A, Cruciani G, Vaz R J (2005) Predictive models for hERG potassium channel blockers. Bioorg Med Chem Lett 15: 3637-3642
12. De Ponti F, Poluzzi E, Cavalli A, Recanatini M, Montanaro N (2002) Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview. Drug Saf 25: 263-286
13. Dobson C M (2004) Chemical space and biology. Nature 432: 824-828
14. Dowell S J, Brown A J (2002) Yeast assays for G-protein-coupled receptors. Receptors Channels 8: 343-352
15. Ekins S, Crumb W J, Sarazan R D, Wikel J H, Wrighton S A (2002) Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel. J Pharmacol Exp Ther 301: 427-434
16. Fitzgerald L W, Burn T C, Brown B S, Patterson J P, Corjay M H, Valentine P A, Sun J H, Link J R, Abbaszade I, Hollis J M, Largent B L, Hartig P R, Hollis G F, Meunier P C, Robichaud A J, Robertson D W (2000) Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. Mol Pharmacol 57: 75-81
17. Fredriksson R, Schioth H B (2005) The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol Pharmacol 67: 1414-1425
18. Freyhult E, Prusis P, Lapinsh M, Wikberg J E, Moulton V, Gustafsson M G (2005) Unbiased descriptor and parameter selection confirms the potential of proteochemometric modelling. BMC Bioinformatics 6: 50
19. Guo L, Guthrie H (2005) Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation. J Pharmacol Toxicol Methods 52: 123-135
20. Guthrie H, Livingston F S, Gubler U, Garippa R (2005) A place for high-throughput electrophysiology in cardiac safety: screening hERG cell lines and novel compounds with the IonWorks HTTM System. J Biomol Screen 10: 832-840
21. Hodder P, Mull R, Cassaday J, Berry K, Strulovici B (2004) Miniaturization of intracellular calcium functional assays to 1536-well plate format using a fluorometric imaging plate reader. J Biomol Screen 9: 417-426
22. Iida A, Nakamura Y (2005) Identification of 156 novel SNPs in 29 genes encoding G-protein coupled receptors. J Hum Genet 50: 182-191
23. Iida A, Saito S, Sekine A, Kataoka Y, Tabei W, Nakamura Y (2004) Catalog of 300 SNPs in 23 genes encoding G-protein coupled receptors. J Hum Genet 49: 194-208
24. Kane J M, Barrett E J, Casey D E, Correll C U, Gelenberg A J, Klein S, Newcomer J W (2004) Metabolic effects of treatment with atypical antipsychotics. J Clin Psychiatry 65: 1447-1455
25. Kiss L, Bennett P B, Uebele V N, Koblan K S, Kane S A, Neagle B, Schroeder K (2003) High throughput ion-channel pharmacology: planar-array-based voltage clamp. Assay Drug Dev Technol 1: 127-135
26. Kornienko O, Lacson R, Kunapuli P, Schneeweis J, Hoffman I, Smith T, Alberts M, Inglese J, Strulovici B (2004) Miniaturization of whole live cell-based GPCR assays using microdispensing and detection systems. J Biomol Screen 9: 186-195
27. Kostenis E, Waelbroeck M, Milligan G (2005) Techniques: Promiscuous G alpha proteins in basic research and drug discovery. Trends Pharmacol Sci 26: 595-602
28. Kroeze W K, Sheffler D J, Roth B L (2003b) G-protein-coupled receptors at a glance. J Cell Sci 116: 4867-4869
29. Kroeze W K, Zhang Y, Mangelsdorf D, Roth B L (in press) Molecular targets for antipsychotic-drug induced weight gain and adverse metabolic consequences. Schizophrenia Research
30. Kroeze W K, Hufeisen S J, Popadak B A, Renock S M, Steinberg S, Ernsberger P, Jayathilake K, Meltzer H Y, Roth B L (2003a) H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 28: 519-526
31. Lapinsh M, Gutcaits A, Prusis P, Post C, Lundstedt T, Wikberg J E (2002a) Classification of G-protein coupled receptors by alignment-independent extraction of principal chemical properties of primary amino acid sequences. Protein Sci 11: 795-805
32. Lapinsh M, Prusis P, Gutcaits A, Lundstedt T, Wikberg J E (2001) Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions. Biochim Biophys Acta 1525: 180-190
33. Lapinsh M, Prusis P, Lundstedt T, Wikberg J E (2002b) Proteochemometrics modeling of the interaction of amine G-protein coupled receptors with a diverse set of ligands. Mol Pharmacol 61: 1465-1475
34. Lapinsh M, Veiksina S, Uhlen S, Petrovska R, Mutule I, Mutulis F, Yahorava S, Prusis P, Wikberg J E (2005) Proteochemometric mapping of the interaction of organic compounds with melanocortin receptor subtypes. Mol Pharmacol 67: 50-59
35. Lipinski C A, Lombardo F, Dominy B W, Feeney P J (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46: 3-26
36. Lyne P D (2002) Structure-based virtual screening: an overview. Drug Discov Today 7: 1047-1055
37. Minic J, Persuy M A, Godel E, Aioun J, Connerton I, Salesse R, Pajot-Augy E (2005) Functional expression of olfactory receptors in yeast and development of a bioassay for odorant screening. Febs J 272: 524-537
38. Muller G (2000) Towards 3D structures of G protein-coupled receptors: a multidisciplinary approach. Curr Med Chem 7: 861-888
39. O'Connor K A, Roth B L (2005) Screening the receptorome for plant-based psychoactive compounds. Life Sci 78: 506-511
40. Palczewski K, Kumasaka T, Hori T, Behnke C A, Motoshima H, Fox B A, Le Trong I, Teller D C, Okada T, Stenkamp R E, Yamamoto M, Miyano M (2000) Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289: 739-745
41. Pausch M H (1997) G-protein-coupled receptors in Saccharomyces cerevisiae: high-throughput screening assays for drug discovery. Trends Biotechnol 15: 487-494
42. Pearlstein R A, Vaz R J, Kang J, Chen X L, Preobrazhenskaya M, Shchekotikhin A E, Korolev A M, Lysenkova L N, Miroshnikova O V, Hendrix J, Rampe D (2003) Characterization of hERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches. Bioorg Med Chem Lett 13: 1829-1835
43. Recanatini M, Poluzzi E, Masetti M, Cavalli A, De Ponti F (2005) QT prolongation through hERG K(+) channel blockade: current knowledge and strategies for the early prediction during drug development. Med Res Rev 25: 133-166
44. Roth B L, Sheffler D J, Kroeze W K (2004a) Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 3: 353-359
45. Roth B L, Lopez E, Beischel S, Westkaemper R B, Evans J M (2004b) Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: a novel approach for CNS drug discovery. Pharmacol Ther 102: 99-110
46. Roth B L, Baner K, Westkaemper R, Siebert D, Rice K C, Steinberg S, Ernsberger P, Rothman R B (2002) Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci U S A 99: 11934-11939
47. Rothman R B, Baumann M H, Savage J E, Rauser L, McBride A, Hufeisen S J, Roth B L (2000) Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation 102: 2836-2841
48. Sanguinetti M C, Mitcheson J S (2005) Predicting drug-hERG channel interactions that cause acquired long QT syndrome. Trends Pharmacol Sci 26: 119-124
49. 2B receptor. Mol Pharmacol 68: 20-33
50. Setola V, Hufeisen S J, Grande-Allen K J, Vesely I, Glennon R A, Blough B, Rothman R B, Roth B L (2003) 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Mol Pharmacol 63: 1223-1229
51. Sheffler D J, Roth B L (2003) Salvinorin A: the 'magic mint' hallucinogen finds a molecular target in the kappa opioid receptor. Trends Pharmacol Sci 24: 107-109
52. Stahura F L, Bajorath J (2002) Bio- and chemo-informatics beyond data management: crucial challenges and future opportunities. Drug Discov Today 7: S41-47
53. Testai L, Bianucci A M, Massarelli I, Breschi M C, Martinotti E, Calderone V (2004) Torsadogenic cardiotoxicity of antipsychotic drugs: a structural feature, potentially involved in the interaction with cardiac HERG potassium channels. Curr Med Chem 11: 2691-2706
54. Venter J C, Adams M D, Myers E W, Li P W, Mural R J, Sutton G G, Smith H O, Yandell M, Evans C A, Holt R A, Gocayne J D, Amanatides P, Ballew R M, Huson D H, Wortman J R, Zhang Q, Kodira C D, Zheng X H, Chen L, Skupski M, Subramanian G, Thomas P D, Zhang J, Gabor Miklos G L, Nelson C, Broder S, Clark A G, Nadeau J, McKusick V A, Zinder N, Levine A J, Roberts R J, Simon M, Slayman C, Hunkapiller M, Bolanos R, Delcher A, Dew I, Fasulo D, Flanigan M, Florea L, Halpern A, Hannenhalli S, Kravitz S, Levy S, Mobarry C, Reinert K, Remington K, Abu-Threideh J, Beasley E, Biddick K, Bonazzi V, Brandon R, Cargill M, Chandramouliswaran I, Charlab R, Chaturvedi K, Deng Z, Di Francesco V, Dunn P, Eilbeck K, Evangelista C, Gabrielian A E, Gan W, Ge W, Gong F, Gu Z, Guan P, Heiman T J, Higgins M E, Ji R R, Ke Z, Ketchum K A, Lai Z, Lei Y, Li Z, Li J, Liang Y, Lin X, Lu F, Merkulov G V, Milshina N, Moore H M, Naik A K, Narayan V A, Neelam B, Nusskern D, Rusch D B, Salzberg S, Shao W, Shue B, Sun J, Wang Z, Wang A, Wang X, Wang J, Wei M, Wides R, Xiao C, Yan C, Yao A, Ye J, Zhan M, Zhang W, Zhang H, Zhao Q, Zheng L, Zhong F, Zhong W, Zhu S, Zhao S, Gilbert D, Baumhueter S, Spier G, Carter C, Cravchik A, Woodage T, Ali F, An H, Awe A, Baldwin D, Baden H, Barnstead M, Barrow I, Beeson K, Busam D, Carver A, Center A, Cheng M L, Curry L, Danaher S, Davenport L, Desilets R, Dietz S, Dodson K, Doup L, Ferriera S, Garg N, Gluecksmann A, Hart B, Haynes J, Haynes C, Heiner C, Hladun S, Hostin D, Houck J, Howland T, Ibegwam C, Johnson J, Kalush F, Kline L, Koduru S, Love A, Mann F, May D, McCawley S, McIntosh T, McMullen I, Moy M, Moy L, Murphy B, Nelson K, Pfannkoch C, Pratts E, Puri V, Qureshi H, Reardon M, Rodriguez R, Rogers Y H, Romblad D, Ruhfel B, Scott R, Sitter C, Smallwood M, Stewart E, Strong R, Suh E, Thomas R, Tint N N, Tse S, Vech C, Wang G, Wetter J, Williams S, Williams M, Windsor S, Winn-Deen E, Wolfe K, Zaveri J, Zaveri K, Abril J F, Guigo R, Campbell M J, Sjolander K V, Karlak B, Kejariwal A, Mi H, Lazareva B, Hatton T, Narechania A, Diemer K, Muruganujan A, Guo N, Sato S, Bafna V, Istrail S, Lippert R, Schwartz R, Walenz B, Yooseph S, Allen D, Basu A, Baxendale J, Blick L, Caminha M, Carnes-Stine J, Caulk P, Chiang Y H, Coyne M, Dahlke C, Mays A, Dombroski M, Donnelly M, Ely D, Esparham S, Fosler C, Gire H, Glanowski S, Glasser K, Glodek A, Gorokhov M, Graham K, Gropman B, Harris M, Heil J, Henderson S, Hoover J, Jennings D, Jordan C, Jordan J, Kasha J, Kagan L, Kraft C, Levitsky A, Lewis M, Liu X, Lopez J, Ma D, Majores W, McDaniel J, Murphy S, Newman M, Nguyen T, Nguyen N, Nodell M, Pan S, Peck J, Peterson M, Rowe W, Sanders R, Scott J, Simpson M, Smith T, Sprague A, Stockwell T, Turner R, Venter E, Wang M, Wen M, Wu D, Wu M, Xia A, Zandieh A, Zhu X (2001) The sequence of the human genome. Science 291: 1304-1351
55. Weber M, Ferrer M, Zheng W, Inglese J, Strulovici B, Kunapuli P (2004) A 1536-well cAMP assay for Gs- and Gi-coupled receptors using enzyme fragmentation complementation. Assay Drug Dev Technol 2: 39-49
56. Wetterling T (2001) Bodyweight gain with atypical antipsychotics. A comparative review. Drug Saf 24: 59-73
57. Wikberg J E, Mutulis F, Mutule I, Veiksina S, Lapinsh M, Petrovska R, Prusis P (2003) Melanocortin receptors: ligands and proteochemometrics modeling. Ann N Y Acad Sci 994: 21-26
58. Wirshing D A, Wirshing W C, Kysar L, Berisford M A, Goldstein D, Pashdag J, Mintz J, Marder S R (1999) Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry 60: 358-363
59. Yan F, Roth B L (2004) Salvinorin A: a novel and highly selective kappa-opioid receptor agonist. Life Sci 75: 2615-2619